|
| Surgery group (n = 22) | Endoscopy group (n = 64) | P value |
| Gender (n, %): |
|
|
|
| Male | 15, 68 | 37, 58 | 0.39 |
| Female | 7, 32 | 27, 42 | |
| Age (median,year) | 61.3 ± 9.6 | 62.4 ± 13.3 | 0.72 |
| Diabetes (%) | 22.7 | 18.8 | 0.45 |
| Blood Urea (g/L) | 0.3 ± 0.1 | 0.4 ± 0.3 | 0.94 |
| Bilirubin (median, kU/L) | 217.4 ± 79.9 | 238 ± 96 | 0.36 |
| CA19.9 (median, kU/L) | 792 ± 613 | 1273 ± 2707 | 0.61 |
| Livermetastasis (n, %) | 4 (18) | 28 (44) | 0.08 |
| Peritoneal Dissemination (n, %) | 1 (4.54%) | 4 (6.25) | 0.53 |
| Stage III/IV (n) | 14/8 | 30/34 | 0.11 |
| Adjuvant Chemotherapy (n) | 6 | 9 | 0.37 |